Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
N,N-Diethylacetamide and N,N-Dipropylacetamide inhibit the NF-kB pathway in in vitro, ex vivo and in vivo models of inflammation-induced preterm birth.
Journal: Scientific reports
Published: October 17, 2024
Maternal Outcomes in Women with Peripartum Cardiomyopathy versus Age and Race-Matched Peers in an Urban US Community.
Journal: Journal of cardiovascular development and disease
Published: June 29, 2022
Management of epidermolysis bullosa simplex in pregnancy: A case report.
Journal: Case reports in women's health
Published: August 05, 2019
Repurposing N,N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth.
Journal: Current pharmaceutical design
Published: January 07, 2018
Showing 1-4 of 4
Last Updated: 09/26/2026